Usefulness of Updated Valve Academic Research Consortium–2 Criteria for Acute Kidney Injury Following Transcatheter Aortic Valve Implantation

Acute kidney injury (AKI) after transcatheter aortic valve implantation (TAVI) is frequent and associated with adverse outcomes. We aimed to identify the incidence and risk factors for AKI after TAVI using the updated Valve Academic Research Consortium–2 classification criteria. We performed a retro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2013-12, Vol.112 (11), p.1807-1811
Hauptverfasser: Konigstein, Maayan, MD, Ben-Assa, Eyal, MD, Abramowitz, Yigal, MD, Steinvil, Arie, MD, MHA, Leshem Rubinow, Eran, MD, MHA, Havakuk, Ofer, MD, Arbel, Yaron, MD, Halkin, Amir, MD, Keren, Gad, MD, Banai, Shmuel, MD, Finkelstein, Ariel, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Acute kidney injury (AKI) after transcatheter aortic valve implantation (TAVI) is frequent and associated with adverse outcomes. We aimed to identify the incidence and risk factors for AKI after TAVI using the updated Valve Academic Research Consortium–2 classification criteria. We performed a retrospective analysis of 300 consecutive patients undergoing TAVI using either Edwards SAPIEN XT or CoreValve bioprostheses at our medical center. Change in serum creatinine from base line to 48 to 72 hours after TAVI was used to define AKI stages 1 to 3. The final study cohort included 251 patients. Overall incidence of AKI was 16.7% (42 of 251); of which, stage 1 AKI was 15.1% (38 of 251), stage 2 AKI was 1.6% (4 of 251), and none had stage 3 AKI or required hemodialysis. All-cause mortality at 30 days and 1 year was greater among patients with AKI (9.5% vs 1%, p
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2013.07.048